A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance. Das C, Bhattacharya A, Adhikari S, Mondal A, et al. Oncogene 2024 May 8. doi: 10.1038/s41388-024-03054.

Read + Share

Amedeo Smart

Independent Medical Education

Das C, Bhattacharya A, Adhikari S, Mondal A, et al. A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance. Oncogene 2024 May 8. doi: 10.1038/s41388-024-03054.
PMID: 38719949